Omega-3

Omega-3 fatty acids are polyunsaturated fats that include alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA and DHA are especially important because they are incorporated into cell membranes and serve as precursors for lipid mediators involved in inflammation and its resolution.

Inflammation and resolution

EPA and DHA alter membrane composition and can influence inflammatory signaling. They also generate specialized pro-resolving mediators such as resolvins, protectins and maresins. These compounds help terminate inflammatory responses rather than simply suppressing them. In older adults, some randomized trials report reductions in inflammatory biomarkers, although effects vary across studies.

Cardiovascular effects

The clearest therapeutic effect is triglyceride reduction. Higher-dose EPA and/or DHA formulations can reduce circulating triglycerides meaningfully and are used clinically in hypertriglyceridemia. Omega-3 intake may also influence endothelial function, platelet activity and cardiac electrophysiology. Cardiovascular outcome trials, however, have produced mixed results depending on formulation and population, so “fish oil” should not be treated as a single uniform intervention.

Brain and retina

DHA is highly concentrated in neuronal and retinal membranes and contributes to membrane fluidity and synaptic function. Observational studies often associate higher fish or omega-3 intake with better cognitive outcomes, but randomized supplementation trials for dementia prevention have been inconsistent. DHA is also a structural component of photoreceptor membranes, giving omega-3 a strong biological role in visual development and retinal physiology.

Muscle, bone and metabolism

Research also covers insulin sensitivity, muscle anabolism, bone remodeling and mitochondrial function. Some trials suggest that EPA/DHA may augment training responses or improve metabolic markers, particularly in people with metabolic dysfunction, but the magnitude and reproducibility of these effects are less established than the triglyceride-lowering effect.

Sources and individual variation

Fatty fish and seafood provide preformed EPA and DHA. Algal oils can provide DHA and, increasingly, EPA and are useful for people avoiding fish. Conversion of plant ALA to EPA and especially DHA is limited and varies with genetics, sex, diet and metabolic context. This is why two people eating the same amount of ALA can have very different long-chain omega-3 status.

Safety

Omega-3 supplements are usually well tolerated. Common issues include fishy aftertaste and gastrointestinal discomfort. Higher doses can modestly affect platelet aggregation and should be considered carefully in people taking anticoagulants or antiplatelet drugs. Product quality also matters because highly unsaturated oils are vulnerable to oxidation; purified, independently tested products reduce concerns about contaminants and rancidity.

Bottom line

EPA and DHA are physiologically important fats with strong evidence for lowering triglycerides and substantial mechanistic relevance to inflammation, membrane biology and the nervous system. Their role as broad anti-aging agents remains plausible but not proven. The most defensible interpretation is targeted use based on diet, cardiovascular risk, triglycerides and clinical context rather than assuming that higher doses are universally better.